HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build
Unknown region code '840'
HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build
Unknown region code '840'
HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions
| Official URL: http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-b2-de113 | Version: 0.1.0 | |||
| Draft as of 2024-08-12 | Computable Name: HepatitisCProceduresCodes | |||
Copyright/Legal: Copyright National Association of Community Health Centers, Inc. (NACHC) |
||||
Codes representing possible values for the Hepatitis C Procedures element
References
Generated Narrative: ValueSet nachc-b2-de113
http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom| Code | Display | Definition |
| NACHC.B2.DE113 | RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) | Hepatitis C Procedures - RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
| NACHC.B2.DE114 | Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) | Hepatitis C Procedures - Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
| NACHC.B2.DE115 | Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) | Hepatitis C Procedures - Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
| NACHC.B2.DE116 | Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) | Hepatitis C Procedures - Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
| NACHC.B2.DE117 | Hepatitis C screening documented as performed (HIV) | Hepatitis C Procedures - Hepatitis C screening documented as performed (HIV) |
| NACHC.B2.DE118 | Patient receiving antiviral treatment for Hepatitis C (HEP-C) | Hepatitis C Procedures - Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
| NACHC.B2.DE119 | Collection of venous blood by venipuncture | Hepatitis C Procedures - Collection of venous blood by venipuncture |
| NACHC.B2.DE120 | Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver | Hepatitis C Procedures - Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |
Generated Narrative: ValueSet
Expansion based on codesystem Extended Codes CodeSystem v0.1.0 (CodeSystem)
This value set contains 8 concepts
| Code | System | Display | Definition |
| NACHC.B2.DE113 | http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom | RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) | Hepatitis C Procedures - RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
| NACHC.B2.DE114 | http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom | Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) | Hepatitis C Procedures - Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
| NACHC.B2.DE115 | http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom | Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) | Hepatitis C Procedures - Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
| NACHC.B2.DE116 | http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom | Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) | Hepatitis C Procedures - Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
| NACHC.B2.DE117 | http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom | Hepatitis C screening documented as performed (HIV) | Hepatitis C Procedures - Hepatitis C screening documented as performed (HIV) |
| NACHC.B2.DE118 | http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom | Patient receiving antiviral treatment for Hepatitis C (HEP-C) | Hepatitis C Procedures - Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
| NACHC.B2.DE119 | http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom | Collection of venous blood by venipuncture | Hepatitis C Procedures - Collection of venous blood by venipuncture |
| NACHC.B2.DE120 | http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom | Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver | Hepatitis C Procedures - Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2021+ National Association of Community Health Centers, Inc. (NACHC). Package fhir.nachc.hiv-cds#0.1.0 based on FHIR 4.0.1. Generated 2024-08-12
Links: Table of Contents |
QA Report
| Version History 
|